Male Infertility Oxidative System
The most accurate, definitive and rapid oxidative stress testing
Male Infertility Challenge
Infertility affects an estimated 15% of couples globally and, according to the World Health Organization1, is a disease defined as failure to achieve pregnancy after 12 months of unprotected sexual intercourse. The male factor plays a role in up to 50% of couples with fertility problems. More importantly up to 50% of male infertility cases worldwide are diagnosed as idiopathic, creating a big challenge for couples and physicians, trying to identify the potential cause and apply an effective treatment2.
About MiOXSYS®
MiOXSYS® is a revolutionary device that has transformed the landscape of male fertility testing. Developed by a team of experts, this cutting-edge technology allows for comprehensive assessments of male reproductive health. By analysing key biomarkers in semen, MiOXSYS® provides a detailed evaluation of sperm quality, oxidative stress, and inflammation levels, all essential factors in understanding and diagnosing male infertility. With its user-friendly interface and rapid results, MIOXSYS offers a reliable and efficient tool for healthcare professionals to provide personalized treatment plans to individuals and couples struggling with infertility. With MiOXSYS®, hope for achieving parenthood is redefined, as it empowers men to take an active role in optimizing their reproductive health.
MiOXSYS® is a rapid in vitro diagnostic semen test that accurately measures oxidative and reductive stress
MiOXSYS’s® sORP measure is based upon the principle of oxidation-reduction potential which measures the giving and taking of electrons.
Unlike other measures, sORP represents an integrated measure of all oxidants & reductants, making it a more clinically meaningful measure when diagnosing idiopathic cases associated with high levels of oxidative stress.
Request a MiOXSYS® System
Want to learn more about the MiOXSYS® System?
Contact for a quote today
References
1 World Health Organisation Laboratory Manual for the Examination and Processing of Human Semen (6th. Ed), 202
2 Agarwal A, Parekh N, Panner Selvam MK, et al. Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility. World J Mens Health. 2019;37(3):296-312. doi:10.5534/wjmh.190055
MiOXSYS is registered for use in the European Union where it is a CE Marked, Mexican COFEPRAS approved product.